Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

Clinical Trial Design: Summary, Recipient Eligibility Criteria, Donor Selection Criteria, Donor/Recipient Seromatching, and Study Conduct

DD Diwakar Davar

Last updated date: Feb 11, 2021 Views: 943 Forks: 0

original An abbreviated version of this protocol was published in Science in Feb, 2021
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

Related files

word 2020-06-18 Protocol v6_TC_17-034 - revDD.doc download
Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Davar, D(2021). Clinical Trial Design: Summary, Recipient Eligibility Criteria, Donor Selection Criteria, Donor/Recipient Seromatching, and Study Conduct. Bio-protocol Preprint. bio-protocol.org/prep834.
  2. Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., Zidi, B., Zhang, S., Badger, J. H., Vetizou, M., Cole, A. M., Fernandes, M. R., Prescott, S., Costa, R. G. F., Balaji, A. K., Morgun, A., Vujkovic-Cvijin, I., Wang, H., Borhani, A. A., Schwartz, M. B., Dubner, H. M., Ernst, S. J., Rose, A., Najjar, Y. G., Belkaid, Y., Kirkwood, J. M., Trinchieri, G. and Zarour, H. M.(2021). Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients. Science 371(6529). DOI: 10.1126/science.abf3363

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.